Omada Health (OMDA) Common Equity (2024 - 2026)

Omada Health has disclosed Common Equity across 3 years of filings, most recently posting $252.7 million for Q2 2026.

• In Q2 2026, Common Equity rose 17.98% year-over-year to $252.7 million; the TTM figure through Jun 2026 stood at $252.7 million (up 17.98% YoY), while the FY2025 annual figure was $229.7 million, up 159.75% from the prior year.
• Common Equity came in at $252.7 million for Q2 2026 at Omada Health, up from $234.1 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $252.7 million in Q2 2026 to a low of -$390.0 million in Q1 2025.
• Average Common Equity over 3 years is -$42.2 million, with a median of $214.2 million recorded in 2025.
• The largest YoY upside for Common Equity was 160.02% in 2026 against a maximum downside of 17.98% in 2026.
• Over 3 years, Common Equity stood at -$384.4 million in 2024, then surged by 159.75% to $229.7 million in 2025, then advanced by 10.04% to $252.7 million in 2026.
• Per Business Quant data, the three most recent Common Equity figures were $252.7 million in Q2 2026, $234.1 million in Q1 2026, and $229.7 million in Q4 2025.